Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Polverino Anthony J., Directeur Scientifique. Officer active across 2 companies, notably Zymeworks Inc.. Cumulatively, 7 disclosures have been recorded. History available since 6 July 2021. The latest transaction was disclosed on 1 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Anthony J. Polverino is the Chief Scientific Officer and Board Member at Zymeworks Inc. and Brainstorm Cell Therapeutics Inc. He is responsible for scientific leadership and innovation within both companies. With a strong background in the biopharmaceutical sector, he plays a key role in developing new therapies and products. His expertise contributes to the strategic direction of the companies.